Current federal regulations still tie the hands of many researchers who wish to study the effects of cannabis. So what needs to change?
The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.
According to the new study from Lancet Psychiatry, a promising treatment for cannabis dependence could be right within reach of many cannabis consumers: CBD.
Sapphire Medical Clinics, one of the few medical cannabis clinics in the UK, has guaranteed the treatment of its first patient for one year.
Which factors are tipping these THC concentrations over the legal limit? The soil? The sun? The strain? Right now, it’s not entirely clear. But one research group at West Virginia University want to change that.
The disease's painful symptoms are often treated with prescription opioids. But a new clinical trial has found that cannabis could be a promising, and safer, substitute.